中源协和: 中源协和细胞基因工程股份有限公司十一届二十次临时董事会会议决议公告

Core Points - The company held its 20th temporary board meeting on July 28, 2025, via communication voting, with all directors ensuring the accuracy and completeness of the announcement [1][2] - The board approved the proposal regarding the acquisition of partial equity held by shareholders of Shanghai Zhongyuan Jisheng Cell Technology Co., Ltd., which was reviewed and passed by the independent directors [1] - The board also approved a proposal for a real estate lease contract with Shanghai Yanlin Biotechnology Co., Ltd., which was similarly reviewed and passed by the independent directors [2] Summary by Category - Board Meeting Details - The meeting was conducted on July 28, 2025, with notifications sent to all directors on July 23, 2025 [1] - The voting was deemed valid as the required directors attended the meeting [1] - Equity Acquisition Proposal - The proposal for acquiring partial equity from Shanghai Zhongyuan Jisheng Cell Technology Co., Ltd. was approved [1] - The independent directors held a special meeting to review this proposal prior to the board meeting [1] - Real Estate Lease Agreement - The board approved a real estate lease contract with Shanghai Yanlin Biotechnology Co., Ltd. [2] - Similar to the equity acquisition, this proposal was also reviewed by independent directors before approval [2]